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ors associated with use of antifungal therapy in patients in the
ntensive care units from third level hospitals in Colombia.
Methods: An observational, analytic, nested, case-control study
as made, based on hospitalized patients. We made a prospective
evision of medical records of adult patients in the intensive care
nit from 5 tertiary care hospitals in Colombia during 3 months.
pidemiological, clinical and microbiological variables were fol-
owed. The case group were conformed by patients with antifungal
herapy, while control group were formed by patients without
ntifungal therapy, paired by date of admission and time stay (3
ontrols per each case). A multivariable logistic regression analysis
as performed with antifungal use as dependent variable.
Results: 492 patients were followed (median hospitalization
ime 8 days), 53,3% (n=263) were male. 26,6% had an infectious
iagnosis at admission, 19,3% (n=97) diabetes, 12% (n=59) can-
er, and 8,7% (n=43) immunosuppression. Mean Apache score at
dmission was 12,3 (SD=6,7), candidemia was detected in 1.3% of
he patients (n =6), andCandidacolonization in 2,2% (n= 11). 26
atients received antimycotic treatment (5.2%), with an incidence
f 61.1 days of use X 1000 patient-days. Factors associated with
ntifungal use in the multivariated model were: at least one site
f colonization (OR= 54,7 CI 95%=2,4 – 1273), medical order for
ungal culture (OR= 19,6 CI 95%= 2,5 - 151.2), use of inotropic
edications(OR=39,4 CI 95%=4,6 – 334,5), parenteral nutrition
OR=50,4 IC95) and fever over 48 hours (OR=78,8 CI 95%=3,8 –
644).
Conclusion: Factors associatedwith antifungal usewere related
o the severity of the clinical condition of the patient. Risk factors
or fungal infections did not usually determined antifungal use.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.495
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iagnostic value of repeated stool testing with enzyme
mmunoassay to conﬁrm Clostridium difﬁcile infection in a ter-
iary care center in Japan
. Norizuki ∗, N. Unuma, Y. Fujiya, T. Sasahara, M. Toshima, H.
omi, Y. Morisawa
Jichi Medical University, Shimotsuke, Japan
Background: Prompt diagnosis of Clostridium difﬁcile infection
CDI) is important for treatment and infection prevention in the
ospital settings. Due to rapidity, low cost, and easy techniques to
erform, the stool enzyme immunoassay (EIA) for C. difﬁcile toxin
and B is one of the most commonly used tests worldwide. Many
liniciansutilize repeatedlyEIA to increase its sensitivity and to rule
ut CDI. However, current guidelines suggest that repeat testing for
DI is of limited value and should be discouraged. The polymerase
hain reaction (PCR) assay for C. difﬁcile toxin is available in some
ountries. At least in Japan, EIA remains the mainstream approach
o diagnose CDI. Thus we conducted a study to evaluate validity of
epeated stool EIA testing for CDI.
Methods: The consecutive laboratory results of EIA for CDIwere
etrospectively reviewed from January 2005 to December 2010 in
tertiary care center in Japan. There was no exclusion. EIA of C.
ifﬁcile toxin was performed using TOX A/B QUIK CHEK® (TECH
AB. Inc, Virginia, the United States). A single episode of diarrheafectious Diseases 16S (2012) e317–e473 e381
was deﬁned as one or more consecutive tests on one patient within
seven-day period. Any tests after seven days were considered as a
new episode of diarrhea.
Results: A total of 4,194 diarrheal episodes in 4,915 tests were
identiﬁed. Among them, 456 (10.9%) were found to be positive for
toxinEIA.Of the456positiveEIA, 411 (90.1%)were foundpositive in
the ﬁrst attempt of EIA, 30 (6.6%) were in the second, and 15 (3.3%)
were in the third.When the initial EIAwas negative, the probability
of the second EIA positivity was 5.7% (29 episodes). When the ﬁrst
two EIA tests were both negative, the probability of the third EIA
positivity was 15% (15 episodes).
Conclusion: Approximately 90% of the patients were given a
diagnosis of CDI in the ﬁrst attempt of EIA. Forty-ﬁve patients con-
ﬁrmed CDI required additional 712 EIA tests with $160 per patient.
In conclusion, the diagnostic value of repeated EIA in C. difﬁcille
testing is limited and repeat EIA testing should be discouraged on
a routine basis.
http://dx.doi.org/10.1016/j.ijid.2012.05.496
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Assessing the implementation of infection prevention and con-
trol at HIV counseling and testing facilities
J.M. Ondieki
National Public Health Laboratory Services, Nairobi, Kenya
Background: The National Quality Assurance Laboratory in col-
laboration with the NPHLS and HIV reference Laboratory carried
out an assessment of twenty two (22) HIV voluntary counseling
and testing sites in Rift Valley Province to determine whether the
VCT sites implement infection prevention and control measures at
their Health care places ofwork inOctober 2010. In this assessment
we looked at the biosafety measures practiced in implementing
infection prevention and control. The biosafety measures assessed
were:
) Use of protective gear by staff
) Segregation of waste using three different containers for col-
lection of used sharps, contaminated waste container and
uncontaminated waste container.
) Use of sodium hypochlorite (Jik) for disinfection
) Use of post exposure prophylaxis procedure
) Use of incinerator for sterilization
f) Washing of hands
Methods: In carrying out the assessment, we used a question-
naire. Staffs at each of the sites visited were interviewed and the
answers obtained recorded.
7/22 (31.8%) were district hospitals, 4/22(18.18%) were health
centers, 5/22 (22.7%) were NGOs, 2/22 (9%) were faith based, 1/22
(4.5%) was a provincial general hospital, and 3/22 were private
hospitals.
Results: It was found out that all sites segregated waste and
hand washing was carried out in all sites. All sites used JIK for
disinfection.
We found out that 10/22 facilities have incinerators, 6/22 facili-
ties burnwaste in air, 17/22 facilities use protective gear, and 16/22
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tionagainsthealth care associate, opportunisticmultidrug resistant
bacteria (MDR) and spores.
http://dx.doi.org/10.1016/j.ijid.2012.05.499382 15th ICID Abstracts / International Journa
acilities have instructions on use of post exposure prophylaxis in
lace.
Conclusion: We concluded that some facilities should to be
rained on the use of incinerators, protective gear, and the post
xposure prophylaxis as a biosafety measure in the implementa-
ion of infection prevention and control at the health care places of
ork.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.497
ype: Poster Presentation
inal Abstract Number: 54.036
ession: Infection Control, Nosocomial Infections & Critical Care
ate: Saturday, June 16, 2012
ime: 12:45-14:15
oom: Poster & Exhibition Area
conomic evaluationof anosocomial infection control program
n Bogota, Colombia: Analysis from a health provider viewpoint
. Ordonez1,∗, C. Saavedra2
HOSPITALUNIVERSITARIO SAN JORGE, Pereira, RISARALDA, Colombia
National University of Colombia, Bogota, Bogota, Colombia
Background:Nosocomial infections (NI) are preventable events
ith a high impact on hospital costs and mortality. Our aim was
o evaluate from the perspective of the health provider the cost-
ffectiveness of a program designed to reduce NI.
Methods: From the medical records database of the institution,
e selected a random sample of patients who acquired infections
hilehospitalizedduring theyear2008.Wealso randomly selected
atients who were admitted the same year but did not acquire
nfections while hospitalized. These non-infected patients were
atched to NI patients by age and diagnosis. Costs were calculated
rom the provider’s perspective and converted from Colombian
esos to US dollars using the average exchange rate of 2008. With
ata from the hospital budget ofﬁce, and based on the costs gen-
rated by the infectious disease committee in 2008, we calculated
osts attributable to NI as well as beneﬁts attained by infections
revented. Beneﬁts were calculated according to sensitivity analy-
es based on the maximum and minimum reduction of NI reported
n the literature.
Results: Hospitalization costs were evaluated in 187 patients
ithNI and276non-infectedpatients.Median total hospitalization
ost was US$6,329 (95% CI US$5,527-7,934) in NI patients, while
n non-infected patients this median cost was US$1,207 (95% CI
S$974-1,495) (Difference between medians US$5,122). Patients
ith NI had longer hospital stays (median 21 days, 95% CI 18-24
ays) than non-infected patients (median 5 days, 95% CI 5-6 days).
ortalitywas alsomarkedly higher in theNI group than in the non-
nfected group (31.6% versus 5.1%). The total cost of implementing a
I control program in 2008 was US$ 101,891. For an 11% reduction
f total NI incidence there is a yearly cost reduction of US$407,388,
nd a beneﬁt:cost ratio of 4:1. If the committee is able to reach the
aximum reported reduction of NI (55%), 398 NI will be avoided
ach year, with an annual cost reduction of US$2,036,941 and a
eneﬁt:cost ratio of 20:1.
Conclusion: NI are costly and preventable events. A NI control
rogram is not only cost-effective from theprovider’s point of view,
ut also it can simultaneously improve key institutional quality
easures.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.498fectious Diseases 16S (2012) e317–e473
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Efﬁcacy and safety in environmental decontaminationwith fog-
ging with superoxidized water XTERIDES® (SW) against Bacillus
atrophaeus spores (BA) andMethicillin resistant staphylococcus
epidermidis (MRSE)
W. Pedreira1,∗, J. Zeballos2, M. Angenscheidt3
1 Hospital Maciel (Public Health Ministry), Montevideo, Uruguay
2 Hospital Maciel (Public Health Ministry), Canelones, Uruguay
3 Emarlan S.A., Montevideo, Uruguay
Background: Cleaning and disinfecting environmental surfaces
in patient care are important in infection control programs. House-
keepers often fail in the cleaning of surfaces: not exceed 50%.
Persistent gram+and– resistant bacteria in environmental surfaces
contribute to the transmission of healthcare-associated pathogens.
SW are emerging as new technologies of disinfection and envi-
ronmental decontamination compared to other methods and fogs:
hydrogenperoxide (steamsandgas);UV radiation. Thosedisadvan-
tages: expensive, staff dedicated these tasks, cannot be used when
roomsareoccupied. XTERIDES®,was approvedas sporicidal, bacte-
ricidal, virucidal against all MDR health care associated pathogens.
not toxic for skin, eyes and mucous, 1 year stability. Efﬁciency of
the XTERIDES® fogging in cystoscopy Urology service artiﬁcially
contaminated selected sites with MRSE and BA w/load of 108 cfu,
in a level III Hospital.
Methods: March, 2011.Clean cistoscopy room (49 m3) were
contaminated with MRSE and BA spores with a load of 108 cfu in
a 9 sites w/9cm in diameter area: leg supports, pads, examination
table, work table, shelves, ﬂoor, instrumental table, sink, edge of
the sink. Samples taken by duplicate of initial inoculums before
fogging the room using SW (lot 307, 265 ppm of active chloride pH
6.5) with a Dyna-Fog® Hurricane, model 2739. 3.8 L. of capacity,
with particles of 5. 3 min fog, 2 min waits. Total 9min fogging
in 15 min. Samples taken by duplicated: 30 min and 19 hrs after
fogging, using a home/made the D/E Neutralizing Agar to avoid the
carryover of the product, during 10 days 35,5◦C.
Results:Adecreaseofmore than6 logufcof initial concentration
for both the vegetative bacteria and spores are found. No regrowth
in closed room after 19 hrs. of application.
Conclusion: Results are very encouraging. To our knowledge
this is the 1st worldwide study showing the efﬁcacy of fogging dis-
infection in high risk Hospital area. 1 Efﬁciency. 2 environmental
and personnel friendly, can be performed in presence of persons
and/or patients; feasibility and very low Costs (1l = 16 Euros). SW
may be an useful compounds for terminal and emergency disinfec-
